Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

50.27
-1.1600-2.26%
Post-market: 50.450.1800+0.36%17:36 EDT
Volume:2.47M
Turnover:124.31M
Market Cap:101.68B
PE:16.08
High:51.03
Open:50.95
Low:50.17
Close:51.43
52wk High:61.70
52wk Low:38.63
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.93
T/O Rate:0.13%
Dividend:1.77
Dividend Rate:3.53%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.24
PE(LYR):13.45

Loading ...

GSK's ViiV Healthcare Highlights New Long-Acting Injectable Data on Cabenuva in HIV Treatment

MT Newswires Live
·
Jul 29

Cabenuva demonstrates superiority to daily oral therapy in adolescents with HIV

TIPRANKS
·
Jul 29

GSK: Hold Rating Reaffirmed as Near-Term Strength Offsets Long-Term Uncertainties; 2,350p Price Target Maintained

TIPRANKS
·
Jul 29

GSK Races To Protect Profits Before Its HIV Blockbuster Faces Generic Rivals

Benzinga Earnings
·
Jul 29

GSK Rises Tuesday, Outperforms Market

Dow Jones
·
Jul 29

GSK Licensor's Late-Stage China Study for Risvutatug Rezetecan in Bone Cancer Meets Primary Endpoint

MT Newswires Live
·
Jul 28

Bernstein Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 28

GSK Heading in Right Direction, but Investors Might Stay on Sidelines

Dow Jones
·
Jul 28

GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline

Dow Jones
·
Jul 28

Stock Track | GSK Soars 5.31% in Pre-Market on Strong Q2 Earnings Beat and Positive Oncology Pipeline Updates

Stock Track
·
Jul 28

Movement Alert|GlaxoSmithKline PLC Rises 4.44% in Regular Trading, Q2 Revenue and Earnings Both Beat Expectations with Cost Savings Target Boosting Confidence

Market Focus
·
Jul 28

GSK to Build New Global Research Center in Cambridge

MT Newswires Live
·
Jul 28

Sector Update: Healthcare Stocks Flat to Higher Pre-Bell Tuesday

MT Newswires Live
·
Jul 28

GSK's R&D Plan Looks Smart

Dow Jones
·
Jul 28

GSK's Savings Plan Can Offset Profitability Hit from HIV Patent Expiration

Dow Jones
·
Jul 28

GSK sees 2031 sales over GBP 40B

TIPRANKS
·
Jul 28

GSK sees 70p per share dividend for FY26

TIPRANKS
·
Jul 28

GSK initiates ‘Accelerate Growth’ program

TIPRANKS
·
Jul 28

GSK Q2 Core Earnings, Sales Rise; Reaffirms 2026 Guidance

MT Newswires Live
·
Jul 28

GSK reports Q2 core EPS 50.5p, up 9% at CER

TIPRANKS
·
Jul 28